Clinical Trials

29 enrolled

Triple Negative Breast Neoplasms

NCT04214626 2025-11-19

R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell Lymphoma

60 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT01630083 2025-06-15

FAST

252 enrolled

CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

NCT03272477 2024-04-17

TP-II

257 enrolled

Breast Neoplasms

NCT06309732 2024-03-13

GAMEC-II

36 enrolled

Genitourinary

Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms

NCT02287129 2023-11-28

MEMORI

75 enrolled

Adenocarcinoma of the Esophagogastric Junction

NCT00525759 2023-11-24

ANZAC

40 enrolled

Breast Neoplasms

NCT00432172 2023-04-03

Selective Neoadjuvant Treatment According to Immunohistochemical Subtype for HER2 Negative Breast Cancer Patients

189 enrolled 17 charts

Breast Neoplasms

NCT00841828 2023-03-31

Trastuzumab Versus Lapatinib as Neoadjuvant Treatment for Her2+ Patients

102 enrolled 10 charts

Breast Neoplasms

NCT01036087 2023-03-30

Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer

47 enrolled 13 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00773695 2023-01-09

A Study of Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast Cancer

150 enrolled

Breast Neoplasms

NCT02050919 2022-03-21

Sorafenib Tosylate, Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With High-Risk Stage IIB-IV Soft Tissue Sarcoma

20 enrolled 14 charts

Sarcoma

NCT02400567 2022-03-15

NeoPAL

125 enrolled

Neoadjuvant Operable Breast Cancer

NCT00193206 2021-11-23

Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer

123 enrolled 8 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00193050 2021-10-26

Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast Cancer

110 enrolled 8 charts

Breast Neoplasms

NCT00464646 2021-10-25

Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer

105 enrolled 17 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00381706 2021-09-29

Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

245 enrolled 15 charts

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT02742051 2021-09-23

A Trial of Neoadjuvant Everolimus Plus Letrozole Versus FEC in Women With ER-positive, HER2-negative Breast Cancer

40 enrolled

Breast Neoplasms

NCT01593020 2021-09-22

Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2

54 enrolled 10 charts

Breast Neoplasms

NCT02132949 2021-09-17

BERENICE

401 enrolled 24 charts

Breast Neoplasms

NCT02909751 2021-05-20

NeoToc

80 enrolled

Breast Neoplasms

NCT03289819 2021-04-08

NIB

53 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02128243 2021-03-26

MATEO

242 enrolled

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Neoplasm Metastasis, Stomach Neoplasms

NCT02685059 2021-02-15

GeparNuevo

174 enrolled

Breast Neoplasms

NCT02682693 2021-02-02

GeparX

780 enrolled

Carcinoma, Ductal, Breast, Inflammatory Breast Neoplasms

NCT04659551 2020-12-09

GIADA

43 enrolled

Breast Neoplasms

NCT00253500 2020-07-24

Epirubicin in Treating Women Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer

15 enrolled

Breast Neoplasms

NCT01855828 2020-03-31

Phase 2 Trial of Pertuzumab and Trastuzumab With Weekly Paclitaxel and Chemotherapy for HER2 Positive Breast Cancer

50 enrolled 13 charts

Her2-Positive Breast Cancer

NCT02789332 2020-03-17

GeparOla

107 enrolled

Kenny-Caffey syndrome, Type 1, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04224922 2020-01-18

Phase II Study of Neoadjuvant Weekly Paclitaxel and Carboplatin Followed by Dose Dense Epirubicin and Cyclophosphamide in Stage II and III Triple Negative Breast Cancer

63 enrolled

Breast Neoplasms

NCT02628613 2019-11-01

Neoadjuvant Paclitaxel Plus Epirubicin Versus Vinorelbine Plus Epirubicin in Breast Cancer With TEKT4 Variations

91 enrolled

Breast Neoplasms

NCT00820547 2019-10-22

Beverly1

100 enrolled

Breast Neoplasms, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

NCT01869192 2019-09-24

Phase II Trial for Large ER-Negative Breast Cancers

72 enrolled 6 charts

Tumor-Agnostic

Neoplasms

NCT00601705 2019-04-30

Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomach

61 enrolled 12 charts

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

NCT00215644 2018-11-02

MATRIX EG

72 enrolled 7 charts

Adenocarcinoma, Esophageal Neoplasms, Stomach Neoplasms

NCT00559845 2018-04-09

A Study of Avastin (Bevacizumab) in Patients With Inflammatory or Locally Advanced Breast Cancer

56 enrolled 10 charts

Breast Neoplasms

NCT01234324 2018-01-23

NEOPECX

171 enrolled

Stomach Neoplasms

NCT01150630 2017-09-01

PACT-15

98 enrolled

Pancreatic Neoplasms

NCT02365805 2017-03-13

BERNAQ

30 enrolled

Breast Neoplasms

NCT00017186 2016-12-07

Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma

Other solid neoplasmThoracic

69 enrolled

Mesothelioma, Malignant

NCT00454636 2016-09-29

A Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer.

158 enrolled 13 charts

Stomach Neoplasms

NCT00379015 2016-09-28

Epirubicin and Cyclophosphamide Followed By Docetaxel and Trastuzumab in Treating Women With HER2-Positive Stage III or Stage IV Breast Cancer

38 enrolled

Breast Neoplasms

NCT01624025 2016-08-17

A Comparative Study of Salvage Treatment With Combination of Docetaxel and Epirubicin

22 enrolled

Metastatic Advanced Gastric Cancer

NCT02846428 2016-07-27

To Evaluate the Efficacy and Safety of Capecitabine Prior to Surgery in Women With Breast Cancer

182 enrolled

Breast Neoplasms

NCT00820053 2016-04-01

A Trial of Adjuvant Transarterial Chemoembolization (TACE) for Preventing Tumor Recurrence After Liver Resection

450 enrolled

Carcinoma, Hepatocellular

NCT00429299 2016-03-22

CHERLOB

121 enrolled 16 charts

Breast Neoplasms

NCT00737438 2016-02-03

Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma

22 enrolled 6 charts

Esophageal Neoplasms, Stomach Neoplasms

NCT00755976 2014-12-31

Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma

32 enrolled

Dermatologic

Melanoma

NCT02307227 2014-12-04

Phase II Study With Trastuzumab + Paclitaxel in Locally Advanced HER2+ Tumors or Epirubicin + Taxotere in HER2- Tumors

46 enrolled